Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1869-6961
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany ; day:4 ; month:10 ; year:2018 ; pages:1-19
Diabetes therapy ; (4.10.2018), 1-19

Contributor
Ziemssen, Focke
Wachtlin, Joachim
Kuehlewein, Laura
Gamulescu, Maria-Andreea
Bertelmann, Thomas
Feucht, Nikolaus
Voegeler, Jessica
Koch, Mirja
Liakopoulos, Sandra
Schmitz-Valckenberg, Steffen
Spital, Georg
SpringerLink (Online service)

DOI
10.1007/s13300-018-0513-2
URN
urn:nbn:de:101:1-2018111408391966872882
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Ziemssen, Focke
  • Wachtlin, Joachim
  • Kuehlewein, Laura
  • Gamulescu, Maria-Andreea
  • Bertelmann, Thomas
  • Feucht, Nikolaus
  • Voegeler, Jessica
  • Koch, Mirja
  • Liakopoulos, Sandra
  • Schmitz-Valckenberg, Steffen
  • Spital, Georg
  • SpringerLink (Online service)

Other Objects (12)

Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy

Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy

Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity

Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity

Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab

Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab

Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study

Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study

Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series

Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series

Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema

Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema

Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy

Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy

Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema

Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema

Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case Report

Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case Report

Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab

Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab

Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases

Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases

Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye

Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye

Related objects